Literature DB >> 31677588

Severe persistent heparin-induced thrombocytopenia in a renal transplant patient.

Divya Chawla1, Ehab Saad1, Talal Khairi1, Anand Padmanabhan2.   

Abstract

Entities:  

Keywords:  ATG; HIT; Heparin-induced thrombocytopenia; Persistent HIT

Mesh：

Substances：

Year:  2019        PMID： 31677588      PMCID： PMC6995266          DOI： 10.1016/j.thromres.2019.10.014

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  10 in total

Review 1.  Successful preemptive renal retransplantation in a patient with previous acute graft loss secondary to HIT type II: a case report and review of literature.

Authors:  Mahvish Muzaffar; Xin Li; Shobha Ratnam
Journal:  Int Urol Nephrol       Date:  2011-03-20       Impact factor: 2.370

2.  A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.

Authors:  Anand Padmanabhan; Curtis G Jones; Brian R Curtis; Daniel W Bougie; Mia J Sullivan; Namrata Peswani; Janice G McFarland; Daniel Eastwood; Demin Wang; Richard H Aster
Journal:  Chest       Date:  2016-02-19       Impact factor: 9.410

3.  Serotonin release assay (SRA)-negative HIT, a newly recognized entity: Implications for diagnosis and management.

Authors:  Komal A Pandya; Eric G Johnson; George A Davis; Anand Padmanabhan
Journal:  Thromb Res       Date:  2018-10-27       Impact factor: 3.944

4.  IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia.

Authors:  Anand Padmanabhan; Curtis G Jones; Shannon M Pechauer; Brian R Curtis; Daniel W Bougie; Mehraboon S Irani; Barbara J Bryant; Jack B Alperin; Thomas G Deloughery; Kevin P Mulvey; Binod Dhakal; Renren Wen; Demin Wang; Richard H Aster
Journal:  Chest       Date:  2017-04-17       Impact factor: 9.410

Review 5.  Peripheral administration of antithymocyte globulins: a review of current literature.

Authors:  Matthew Wolf; Jillian L Descourouez; David R Hager; Arjang Djamali
Journal:  Transplant Rev (Orlando)       Date:  2012-12-29       Impact factor: 3.943

6.  Heparin-induced thrombocytopenia in a renal transplant recipient.

Authors:  Brent A Anderegg; G Mark Baillie; Angello Lin; John Lazarchick
Journal:  Am J Transplant       Date:  2005-06       Impact factor: 8.086

7.  Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin : clinical implications for heparin-induced thrombocytopenia.

Authors:  C Pouplard; M A May; S Iochmann; J Amiral; A M Vissac; M Marchand; Y Gruel
Journal:  Circulation       Date:  1999-05-18       Impact factor: 29.690

8.  Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies.

Authors:  Caroline Vayne; Eve-Anne Guery; Claire Kizlik-Masson; Jérôme Rollin; Anne Bauters; Yves Gruel; Claire Pouplard
Journal:  Br J Haematol       Date:  2017-10-19       Impact factor: 6.998

9.  Heparin-induced thrombocytopenia type II: a serious hazard in preemptive renal transplantation: a case report.

Authors:  S Dracopoulos; V Vougas; T I Kassimatis; T Theodoridis; M E Ali; T Apostolou
Journal:  Transplant Proc       Date:  2007-12       Impact factor: 1.066

10.  Timeline of heparin-induced thrombocytopenia seroconversion in serial plasma samples tested using an automated latex immunoturbidimetric assay.

Authors:  Theodore E Warkentin; Jo-Ann I Sheppard; James W Smith; Donald M Arnold; Ishac Nazy
Journal:  Int J Lab Hematol       Date:  2019-05-03       Impact factor: 2.877
  10 in total
  1 in total

1.  A prospective, blinded study of a PF4-dependent assay for HIT diagnosis.

Authors:  Bethany Samuelson Bannow; Deepti M Warad; Curtis G Jones; Shannon M Pechauer; Brian R Curtis; Daniel W Bougie; Ruchika Sharma; Diane E Grill; Mary W Redman; Parisa R Khalighi; Rachel R Leger; Rajiv K Pruthi; Dong Chen; Daniel E Sabath; Richard H Aster; David A Garcia; Anand Padmanabhan
Journal:  Blood       Date:  2021-02-25       Impact factor: 25.476
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.